Delineating Avenues for a Novel Disease Modifying Therapy for Parkinson's Disease Using Advanced Fluorescence Microscopy Techniques.
Date
2018-08
Authors
Contributor
Advisor
Department
Instructor
Depositor
Speaker
Researcher
Consultant
Interviewer
Narrator
Transcriber
Annotator
Journal Title
Journal ISSN
Volume Title
Publisher
Volume
Number/Issue
Starting Page
Ending Page
Alternative Title
Abstract
The most common mutation linked to Parkinson’s disease (PD) is the G2019S mutation
of the leucine rich repeat kinase 2 (LRRK2) gene. LRRK2 is kinase active as a dimer and is
involved in cellular maintenance through regulation of endocytosis and vesicle trafficking. The
G2019S mutation has been shown to increase the kinase activity two-fold. I utilized advanced
fluorescence microscopy techniques in live differentiated human neuroblastoma (SH-SY5Y)
cells transfected with WT LRRK2-EGFP (WT) or G2019S LRRK2-EGFP (G2019S) to
determine how the G2019S mutation affects the dynamics of LRRK2-EGFP within the cell and
alters its association with substrates, Rab7 and EndophilinA1 (EndoA1). On the plasma
membrane, G2019S expressing cells contained significantly higher levels of dimer species and
large protein aggregates compared to WT expressing cells. G2019S was also found to have
significantly higher levels of self-association and protein aggregation in the cytosol. These
findings suggest that the G2019S variant of LRRK2 has an increased propensity to self-associate
in the cytosol and on the plasma membrane. I also found alterations to LRRK2 substrate
interactions with Rab7 and EndoA1, which likely affect the function of these proteins.
Furthermore, because LRRK2 kinase inhibitors have been the focus of recent PD drug
development, I also treated cells with well-studied inhibitors, MLi2, LRRK2-IN1, GNE-0877,
and GNE-7915, to determine their effects on the intracellular dynamics of LRRK2-EGFP.
Treatment of transfected cells with LRRK2 kinase inhibitors showed a significant increase in
LRRK2 aggregation in the cytosol and at the plasma membrane. The effect that these aggregates
have on cell function could affect their use as clinical treatments and warrants further study.
Ultimately, these experiments provide vital information about the dynamics of LRRK2 and the
effect of G2019S mutation and kinase inhibitor treatment in a novel context.
Description
Keywords
Fluorescence Microscopy, Parkinson’s disease, LRRK2, EndophilinA1, Rab Proteins
Citation
Extent
Format
Geographic Location
Time Period
Related To
Related To (URI)
Table of Contents
Rights
All UHM dissertations and theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission from the copyright owner.
Rights Holder
Local Contexts
Collections
Email libraryada-l@lists.hawaii.edu if you need this content in ADA-compliant format.